NSRX Stock Summary and Trading Ideas (Nasus Pharma Ltd. | AMEX:NSRX)

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Nasus Pharma Ltd. trades on the AMEX stock market under the symbol NSRX.

As of April 1, 2026, NSRX stock price climbed to $2.55 with 42,877 million shares trading.

NSRX has a beta of 1.51, meaning it tends to be more sensitive to market movements. NSRX has a correlation of 0.03 to the broad based SPY ETF.

NSRX has a market cap of $29.86 million. This is considered a Sub-Micro Cap stock.

NSRX support price is $1.98 and resistance is $2.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NSRX shares will trade within this expected range on the day.